MedSci参加第6届中国蛋白质组学大会

2009-08-03 MedSci原创 MedSci原创

2009年7月29日至31日在江苏泰州举办的第6届中国蛋白质组学大会,本次大会由中国生物化学与分子生物学会蛋白质组学专业委员会(CNHUPO)主办,北京蛋白质组研究中心和复旦大学共同承办。MedSci工作人员参加了此次盛会。 大会开幕式由中国生物化学与分子生物学会蛋白质组学专业委员会执行主席杨晓明主持,中国生物化学与分子生物学会蛋白质组学专业委

   2009年7月29日至31日在江苏泰州举办的第6届中国蛋白质组学大会,本次大会由中国生物化学与分子生物学会蛋白质组学专业委员会(CNHUPO)主办,北京蛋白质组研究中心和复旦大学共同承办。MedSci工作人员参加了此次盛会。

   大会开幕式由中国生物化学与分子生物学会蛋白质组学专业委员会执行主席杨晓明主持,中国生物化学与分子生物学会蛋白质组学专业委员会会议主席、中国科学院贺福初院士,南开大学校长、中国科学院饶子和院士,上海东方肝胆外科研究所副所长、中国工程院王红阳院士,科技部基础研究司张先恩司长,总后卫生部王玉民副部长,国家自然科学基金委员会沈岩副主任,国家科技部生物工程技术研究中心马宏建副主任,军事医学科学院科技部徐卸古部长,复旦大学化学系杨芃原教授,江苏省人民政府曹卫星副省长,江苏省泰州市市委张雷书记,江苏省泰州市姚建华市长,扬子江药业集团徐镜人董事长等应邀出席。来自科研院所、高校及仪器厂商等不同领域的600多名代表参加了本次大会。这次会议有力地促进了中国蛋白质组学专家和学者的学术交流与合作。人类蛋白质组研究对直接揭示生命活动规律和本质、发现人类重大疾患发生发展规律具有深远的意义。

    本届会议主要讨论蛋白质组学研究的现状及其进展,内容包括:人类蛋白质组计划、疾病蛋白质组学、功能蛋白质组学、药物蛋白质组学、结构蛋白质组学、蛋白质化学、生物信息学、蛋白质修饰和相互作用、抗体相关技术、蛋白质组微分析、蛋白质芯片以及蛋白质组新技术新方法等研究领域。

    MedSci有幸参与此次盛会,并与予会专家,学者进行了广泛而深入地交流,许多专家对MedSci的服务给予高度评价和支持,我们也一如既往保持高质量的编辑风格,坚持“选择我们,脱颖而出”的服务宗旨。

蛋白质组大会参会代表

大会主席台

MedSci编辑与饶子和院士合影

MedSci编辑与贺福初院士合影

MedSci相关动态:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1754797, encodeId=98b11e54797c1, content=<a href='/topic/show?id=0a1688e33b3' target=_blank style='color:#2F92EE;'>#蛋白质组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88733, encryptionId=0a1688e33b3, topicName=蛋白质组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf6736789983, createdName=jjjiang0211, createdTime=Mon Jun 07 20:37:00 CST 2010, time=2010-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765462, encodeId=99fb1e65462a3, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Dec 15 00:37:00 CST 2009, time=2009-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537, encodeId=4c2353e1e, content=你们厉害 , beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb885167, createdName=medomm, createdTime=Wed Aug 19 01:01:00 CST 2009, time=2009-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296841, encodeId=38251296841a1, content=<a href='/topic/show?id=158288e017c' target=_blank style='color:#2F92EE;'>#蛋白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88701, encryptionId=158288e017c, topicName=蛋白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Aug 05 09:37:00 CST 2009, time=2009-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605499, encodeId=ac9a160549921, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Aug 05 09:37:00 CST 2009, time=2009-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524, encodeId=3b9d52492, content=牛,都与院士合影呢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=proteinase, createdTime=Tue Aug 04 21:18:00 CST 2009, time=2009-08-04, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1754797, encodeId=98b11e54797c1, content=<a href='/topic/show?id=0a1688e33b3' target=_blank style='color:#2F92EE;'>#蛋白质组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88733, encryptionId=0a1688e33b3, topicName=蛋白质组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf6736789983, createdName=jjjiang0211, createdTime=Mon Jun 07 20:37:00 CST 2010, time=2010-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765462, encodeId=99fb1e65462a3, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Dec 15 00:37:00 CST 2009, time=2009-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537, encodeId=4c2353e1e, content=你们厉害 , beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb885167, createdName=medomm, createdTime=Wed Aug 19 01:01:00 CST 2009, time=2009-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296841, encodeId=38251296841a1, content=<a href='/topic/show?id=158288e017c' target=_blank style='color:#2F92EE;'>#蛋白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88701, encryptionId=158288e017c, topicName=蛋白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Aug 05 09:37:00 CST 2009, time=2009-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605499, encodeId=ac9a160549921, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Aug 05 09:37:00 CST 2009, time=2009-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524, encodeId=3b9d52492, content=牛,都与院士合影呢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=proteinase, createdTime=Tue Aug 04 21:18:00 CST 2009, time=2009-08-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1754797, encodeId=98b11e54797c1, content=<a href='/topic/show?id=0a1688e33b3' target=_blank style='color:#2F92EE;'>#蛋白质组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88733, encryptionId=0a1688e33b3, topicName=蛋白质组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf6736789983, createdName=jjjiang0211, createdTime=Mon Jun 07 20:37:00 CST 2010, time=2010-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765462, encodeId=99fb1e65462a3, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Dec 15 00:37:00 CST 2009, time=2009-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537, encodeId=4c2353e1e, content=你们厉害 , beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb885167, createdName=medomm, createdTime=Wed Aug 19 01:01:00 CST 2009, time=2009-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296841, encodeId=38251296841a1, content=<a href='/topic/show?id=158288e017c' target=_blank style='color:#2F92EE;'>#蛋白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88701, encryptionId=158288e017c, topicName=蛋白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Aug 05 09:37:00 CST 2009, time=2009-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605499, encodeId=ac9a160549921, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Aug 05 09:37:00 CST 2009, time=2009-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524, encodeId=3b9d52492, content=牛,都与院士合影呢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=proteinase, createdTime=Tue Aug 04 21:18:00 CST 2009, time=2009-08-04, status=1, ipAttribution=)]
    2009-08-19 medomm

    你们厉害

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1754797, encodeId=98b11e54797c1, content=<a href='/topic/show?id=0a1688e33b3' target=_blank style='color:#2F92EE;'>#蛋白质组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88733, encryptionId=0a1688e33b3, topicName=蛋白质组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf6736789983, createdName=jjjiang0211, createdTime=Mon Jun 07 20:37:00 CST 2010, time=2010-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765462, encodeId=99fb1e65462a3, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Dec 15 00:37:00 CST 2009, time=2009-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537, encodeId=4c2353e1e, content=你们厉害 , beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb885167, createdName=medomm, createdTime=Wed Aug 19 01:01:00 CST 2009, time=2009-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296841, encodeId=38251296841a1, content=<a href='/topic/show?id=158288e017c' target=_blank style='color:#2F92EE;'>#蛋白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88701, encryptionId=158288e017c, topicName=蛋白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Aug 05 09:37:00 CST 2009, time=2009-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605499, encodeId=ac9a160549921, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Aug 05 09:37:00 CST 2009, time=2009-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524, encodeId=3b9d52492, content=牛,都与院士合影呢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=proteinase, createdTime=Tue Aug 04 21:18:00 CST 2009, time=2009-08-04, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1754797, encodeId=98b11e54797c1, content=<a href='/topic/show?id=0a1688e33b3' target=_blank style='color:#2F92EE;'>#蛋白质组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88733, encryptionId=0a1688e33b3, topicName=蛋白质组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf6736789983, createdName=jjjiang0211, createdTime=Mon Jun 07 20:37:00 CST 2010, time=2010-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765462, encodeId=99fb1e65462a3, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Dec 15 00:37:00 CST 2009, time=2009-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537, encodeId=4c2353e1e, content=你们厉害 , beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb885167, createdName=medomm, createdTime=Wed Aug 19 01:01:00 CST 2009, time=2009-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296841, encodeId=38251296841a1, content=<a href='/topic/show?id=158288e017c' target=_blank style='color:#2F92EE;'>#蛋白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88701, encryptionId=158288e017c, topicName=蛋白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Aug 05 09:37:00 CST 2009, time=2009-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605499, encodeId=ac9a160549921, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Aug 05 09:37:00 CST 2009, time=2009-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524, encodeId=3b9d52492, content=牛,都与院士合影呢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=proteinase, createdTime=Tue Aug 04 21:18:00 CST 2009, time=2009-08-04, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1754797, encodeId=98b11e54797c1, content=<a href='/topic/show?id=0a1688e33b3' target=_blank style='color:#2F92EE;'>#蛋白质组#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88733, encryptionId=0a1688e33b3, topicName=蛋白质组)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf6736789983, createdName=jjjiang0211, createdTime=Mon Jun 07 20:37:00 CST 2010, time=2010-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1765462, encodeId=99fb1e65462a3, content=<a href='/topic/show?id=252ae1803a3' target=_blank style='color:#2F92EE;'>#白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71803, encryptionId=252ae1803a3, topicName=白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=778d36, createdName=柳叶一刀, createdTime=Tue Dec 15 00:37:00 CST 2009, time=2009-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=537, encodeId=4c2353e1e, content=你们厉害 , beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb885167, createdName=medomm, createdTime=Wed Aug 19 01:01:00 CST 2009, time=2009-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1296841, encodeId=38251296841a1, content=<a href='/topic/show?id=158288e017c' target=_blank style='color:#2F92EE;'>#蛋白质#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88701, encryptionId=158288e017c, topicName=蛋白质)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Wed Aug 05 09:37:00 CST 2009, time=2009-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605499, encodeId=ac9a160549921, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Wed Aug 05 09:37:00 CST 2009, time=2009-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=524, encodeId=3b9d52492, content=牛,都与院士合影呢。, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=proteinase, createdTime=Tue Aug 04 21:18:00 CST 2009, time=2009-08-04, status=1, ipAttribution=)]
    2009-08-04 proteinase

    牛,都与院士合影呢。

    0

相关资讯

杨帆谈申报国家自然科学基金青年基金体会

杨帆谈申报国家自然科学基金青年基金体会 发表日期:2008年12月1日 下面就我申报基金的一点体会和大家交流。 一、在选题上要下功夫 1、选题要强调发挥主动性 国家自然科学基金和其他纵向科研课题,特别是预研课题的主要区别在于题目不是限定的,尤其是面上项目和青年基金项目完全由申请者自主提出,强调自由探索。即使是重大项目和重点项目,也是由工作在各学科前沿的一群科研工作者自主提出某个主题后,经研

有关中文期刊影响因子的说明

我们经常能看到"中文期刊影响因子",同时不少作者经常询问我们一些国内的中文杂志,想查询这些杂志的影响因子。这里进行相关的说明: 1 我们通常说的影响因子,指的是SCI杂志的影响因子,是全球公认的,也是最权威的评定标准。在这里可以查询到所有的杂志 http://www.medsci.cn/sciif.asp ,全球总共有近7000种杂志,中国(包括香港,台湾)仅147种杂

生物医学期刊投稿的统一要求

国际医学期刊编辑委员会 International Committee of Medical Journal Editors (Annals of Internal Medicine,1997,126(1):36-47)1978年,一小组综合性医学期刊编辑在加拿大不列颠哥伦比亚省温哥华市非正式集会,制定了向这些编辑所属期刊投稿格式的标准。后来,该小组以温哥华小组(Vancouver Group

第一篇SCI文章发表感想[转载]

这篇与大家分享! 2007年10月1日 在线投稿(想粘粘国庆节的喜气)2007年11月7日 修回(minor revision)2007年11月27日 修回稿在线投稿2008年1月13日 二次minor revision2008年1月15日 二次修回稿投稿2008年1月18日 接受 前天上网收邮件的时候,没有想到盼望已久的接受信就已经静静在信箱里了,当时心

英文SCI论文写作、投稿过程中的注意事项

【写作前准备】 1、自己的实验结果是否够发一篇SCI文章? 2、适合发表在什么杂志?是选择专业期刊?还是综合期刊? 3、为什么类型的投稿(Types of submission)?比如Articles(论著);Reviews(综述);Reports(报告);Letter to editor(来信)等。 4、该杂志的影响因子(Impact factor)是多少,每年发表多少文章?是否有过本土中国人在

填写国家自然科学基金申请书应该注意的一些细节

现在正是各路英豪填写国家自然科学基金申请书热火朝天的时候,作为一名填写申请书不知疲倦的老战士,也作为同行评议人和免疫学科评审专家,我好像可以说上几句话。 拥有良好的科研切入点和思路是开展研究工作的必要条件,但如果在填写基金申请书不善于表达则很难通过越来越苛刻的评审之关。撰写论文被一家杂志